Create Account | Sign In: Author or Forum

Search Symptoms

Category: Dermatology | Monthly Briefing

Back to Journal Articles

December 2012 Briefing - Dermatology

Last Updated: January 01, 2013.

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for December 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Derm-Path Training Linked to Fewer Diagnosis Discrepancies

FRIDAY, Dec. 28 (HealthDay News) -- Fewer diagnostic discrepancies are seen for pathologists with dermatopathology fellowship training, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Understanding of Infantile Hemangiomas Is Improving

THURSDAY, Dec. 27 (HealthDay News) -- Improved understanding of the pathogenesis of infantile hemangiomas (IHs) is leading to better treatment options, according to a review published online Dec. 24 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Most Dermatologists Able to Spot Psychocutaneous Disease

WEDNESDAY, Dec. 26 (HealthDay News) -- While the majority of dermatologists feel capable of diagnosing psychocutaneous disease, most are also uncomfortable starting antidepressants or antipsychotics and feel unsuccessful in treating these conditions, according to research published in the January issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Varizig Approved to Reduce Chickenpox Symptoms

FRIDAY, Dec. 21 (HealthDay News) -- Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus that causes the disease.

More Information

Motor Vehicle Incidents Common in Medical Residents

FRIDAY, Dec. 21 (HealthDay News) -- During training, internal medicine residents commonly experience motor vehicle incidents, including crashes and near misses, but less commonly experience blood and body fluid (BBF) exposures, according to research published in the December issue of the Mayo Clinic Proceedings.

Abstract
Full Text (subscription or payment may be required)

Vertex Announces Boxed Warning on Hepatitis C Drug

WEDNESDAY, Dec. 19 (HealthDay News) -- In the wake of multiple deaths, the oral hepatitis C drug telaprevir (Incivek) will now carry a boxed warning, according to a statement released Dec. 19 by Vertex Pharmaceuticals.

More Information

Many Docs Use Social Media to Find, Share Medical Data

WEDNESDAY, Dec. 19 (HealthDay News) -- Most physicians use social media on at least a weekly basis, and report that it improves the quality of patient care they deliver, according to a study published in the September/October issue of the Journal of Medical Internet Research.

Full Text

Adalimumab Relieves Hidradenitis Suppurativa

TUESDAY, Dec. 18 (HealthDay News) -- For patients with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin disease characterized by painful abscesses, nodules, and draining fistulas in the axilla and groin, treatment with once-weekly adalimumab is associated with improvements in pain and inflammation, according to a study published online Dec. 17 in the Annals of Internal Medicine.

Full Text (subscription or payment may be required)

Health Care Satisfaction Rated As High by Unacculturated Hispanics

MONDAY, Dec. 17 (HealthDay News) -- Hispanic patients, particularly unacculturated Hispanics, rate their health care experience more highly than do other patient groups, according to a study published in the October issue of the Journal of Immigrant and Minority Health.

Abstract
Full Text (subscription or payment may be required)

UV Nail Lamps Do Not Significantly Up Skin Cancer Risk

FRIDAY, Dec. 14 (HealthDay News) -- Ultraviolet (UV) nail lamps, used for professional and personal nail techniques, do not pose a clinically significant skin cancer risk, according to a letter to the editor published online Dec. 6 in the Journal of Investigative Dermatology.

Full Text

Drug Combinations Target Mutant BRAF Melanomas

FRIDAY, Dec. 14 (HealthDay News) -- Melanomas carrying mutations that make them resistant to many drugs can be effectively targeted by drug combinations, some of which include statins, according to a study published online Dec. 13 in Cancer Discovery.

Abstract
Full Text (subscription or payment may be required)

Current Health Costs Pushing Docs to Make Urgent Choices

WEDNESDAY, Dec. 12 (HealthDay News) -- The current growth in health care's share of the gross domestic product (GDP) and need to implement learning health systems is forcing physicians to make important choices, according to a perspective piece published online Dec. 12 in the New England Journal of Medicine.

Full Text

Number of Independent Physicians Continues to Decline

MONDAY, Dec. 10 (HealthDay News) -- Physician business models are transforming, with a sustained shift away from independent practice, according to report released by the consulting firm Accenture.

More Information

Health Care Law Boosts Savings on Meds for Medicare Recipients

FRIDAY, Dec. 7 (HealthDay News) -- Savings on prescription drugs related to the Affordable Care Act have reached $5.1 billion, according to a Dec. 3 news release from the U.S. Department of Health and Human Services.

More Information

Anticompetitive Market Power Common in Managed Care Plans

FRIDAY, Dec. 7 (HealthDay News) -- For each of the three most popular types of managed care plans in the United States (point-of-service plan [POS], health maintenance organization [HMO], and preferred provider organization [PPO]), anticompetitive market power is widespread, according to a Nov. 28 news release from the American Medical Association (AMA).

More Information

FDA: Public-Private Venture Set to Improve Regulatory Science

THURSDAY, Dec. 6 (HealthDay News) -- The Medical Device Innovation Consortium (MDIC), the first public-private partnership to promote medical device regulatory science, has been established, according to a Dec. 3 news release issued by the U.S. Food and Drug Administration.

More Information

Five-Hour Protected Sleep Feasible for Medical Interns

TUESDAY, Dec. 4 (HealthDay News) -- Implementation of a five-hour period of protected sleep is feasible for medical interns on long shifts, resulting in interns getting more uninterrupted sleep and feeling more alert the next day, according to a study published in the Dec. 5 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Lower BMI, Especially in Boys, Has Protective Effect in Acne

TUESDAY, Dec. 4 (HealthDay News) -- Family history, body mass index, and diet are all linked to the risk of moderate-to-severe acne in young adults, according to a study published in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Topical Simvastatin Accelerates Wound Healing in Diabetes

MONDAY, Dec. 3 (HealthDay News) -- Topically applied simvastatin accelerates wound healing by directly influencing lymphatics and indirectly via recruitment of macrophages, according to a study published in the December issue of The American Journal of Pathology.

Abstract
Full Text (subscription or payment may be required)

Increasing Number of Workers in Self-Insured Health Plans

MONDAY, Dec. 3 (HealthDay News) -- There has been a recent increase in the percentage of workers in the private sector who are enrolled in self-insured health plans, in which the employer assumes the financial risk related to health insurance (unlike a fully-insured plan, where the insurance company assumes the risk), according to research published in the November issue of the Employee Benefit Research Institute's Notes.

More Information

Recent Increase in Adverse TMP-SMX Reactions in Children

MONDAY, Dec. 3 (HealthDay News) -- There has been a significant increase in adverse drug reactions (ADRs) associated with use of trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of skin and soft tissue infection (SSTI) in children, according to research published online Dec. 3 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)


Previous: December 2012 Briefing - Cardiology Next: December 2012 Briefing - Diabetes & Endocrinology

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: